NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens

Cell Research

Volumn 22, Issue 5, 2012, Pages 836-847

  Yao, Yikun ^a   Wang, Yalong ^a   Chen, Fuxiang ^b   Huang, Yin ^a   Zhu, Shu ^a   Leng, Qibin ^c   Wang, Hongyan ^d   Shi, Yufang ^a   Qian, Youcun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c INSTITUTE PASTEUR OF SHANGHAI   (China)

^d Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

infection; inflammasome; MHC class I; NLRC5

Indexed keywords

CARRIER PROTEIN; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERFERON; NLRC5 PROTEIN, MOUSE; NLRP3 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ANIMAL; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; GENETICS; IMMUNOLOGY; LISTERIA MONOCYTOGENES; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; MOUSE MUTANT; PATHOGENICITY;

ANIMALS; ANTIGEN PRESENTATION; CARRIER PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; INFLAMMASOMES; INTERFERON TYPE I; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LISTERIA MONOCYTOGENES; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; NF-KAPPA B;

LISTERIA MONOCYTOGENES; MUS;

EID: 84862022239     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2012.56     Document Type: Article

References (28)

1. Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140:821-832.
2. ElinaV E, Strowig T, Henao-Mejia J, FlaVell RA. Regulation of the antimicrobial response by NLR proteins. Immunity 2011; 34:665-679.
3. Kanneganti TD. Central roles of NLRs and inflammasomes inViral infection. Nat. Re.V Immunol 2010; 10:688-698.
4. Kanneganti TD, Lamkanfi M, Núñez G. Intracellular NODlike receptors in host defense and disease. Immunity 2007; 27:549-559.
5. DaVis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu ReV Immunol 2011; 29:707-735.
6. Sorbara MT, Girardin SE. Mitochondrial ROS fuel the inflammasome. Cell Res 2011; 21:558-560.
7. Lamkanfi M, Kanneganti TD. Regulation of immune pathways by the NOD-like receptor NLRC5. Immunobiology 2011; 217:13-16.
8. Magalhaes JG, Sorbara MT, Girardin SE, Philpott DJ. What is new with Nods? Curr. Opin. Immunol. 2010; 23:29-34.
9. Meissner TB, Li A, Kobayashi KS. NLRC5: D newly discoVered MHC class I transactiVator (CITA). Microbes Infect 2011 Dec 22. doi:10.1016/j.micinf.2011. 12.007
10. Neerincx A, Lautz K, Menning M, et al. A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiViral responses. J Biol. Chem. 2010; 285:26223-26232.
11. Meissner TB, Li A, Biswas A, et al. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc Natl Acad Sci USA 2010; 107:13794-13799.
12. Cui J, Zhu L, Xia X, et al. NLRC5 negatiVely regulates the NF-kappaB and type I interferon signaling pathways. Cell 2010; 141:483-496.
13. Benko S, Magalhaes JG, Philpott DJ, Girardin SE. NLRC5 limits the actiVation of inflammatory pathways. J Immunol 2010; 185:1681-1691.
14. Kuenzel S, Till A, Winkler M, et al. The nucleotide-binding oligomerization domain-like receptor NLRC5 is inVolVed in IFN-dependent antiViral immune responses. J Immunol 2010; 184:1990-2000.
15. Meissner TB, Li A, Liu YJ, Gagnon E, Kobayashi KS. The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactiVation actiVity. Biochem Biophys Res Commun 2012; 418:786-791.
16. DaVis BK, Roberts RA, Huang MT, et al. Cutting edge: NLRC5- dependent actiVation of the inflammasome. J Immunol 2010; 186:1333-1337.
17. Kumar H, Pandey S, Zou J, et al. NLRC5 deficiency does not influence cytokine induction byVirus and bacteria infections. J Immunol 2010; 186:994-1000.
18. Zijlstra M, Bix M, Simister NE, et al. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 1990; 344:742-746.
19. Neefjes J, Jongsma ML, Paul P, Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Re.V Immunol 2011; 11:823-836.
20. Martinon F, PetrilliV, Mayor A, TardiVel A, Tschopp J. Goutassociated uric acid crystals actiVate the NALP3 inflammasome. Nature 2006; 440:237-241.
21. Meixenberger K, Pache F, Eitel J, et al. Listeria monocytogenes- infected human peripheral blood mononuclear cells produce IL-1beta, depending on listeriolysin O and NLRP3. J Immunol 2009; 184:922-930.
22. Zika E, Ting JP. Epigenetic control of MHC-II: Interplay between CIITA and histone-modifying enzymes. Curr. Opin. Immunol. 2005; 17:58-64.
23. Chang CH, Guerder S, Hong SC,Van Ewijk W, FlaVell RA. Mice lacking the MHC class II transactiVator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 1996; 4:167-178.
24. Masternak K, Muhlethaler-Mottet A,Villard J, et al. CIITA is a transcriptional coactiVator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes DeV 2000; 14:1156-1166.
25. Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176:1693-1702.
26. Zhu S, Pan W, Shi P, et al. Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling. J Exp Med 2010; 207:2647-2662.
27. Hayashi T, Hideshima T, Akiyama M, et al. ExViVo induction of multiple myeloma-specific cytotoxic T lymphocytes. Blood 2003; 102:1435-1442.
28. Xu H, Chun T, Choi HJ, Wang B, Wang CR. Impaired response to Listeria in H2-M3-deficient mice reVeals a nonredundant role of MHC class Ib-specific T cells in host defense. J Exp Med 2006; 203:449-459.